Why the study?
COPD commonly coexists with CHD, but the association between the triglyceride-total cholesterol-body mass index (TCBI) and CHD in COPD patients had not been examined.
Is a higher triglyceride-total cholesterol-body mass index (TCBI) associated with a lower prevalence of coronary heart disease in COPD patients undergoing coronary angiography?
Observational (n=407)
No
Is a higher triglyceride-total cholesterol-body mass index (TCBI) associated with a lower prevalence of coronary heart disease in COPD patients undergoing coronary angiography?
Effect estimate: OR 0.927 per 100-unit increase in TCBI (95% CI 0.879-0.976)
p-value: p=0.004
Higher TCBI is independently associated with a lower likelihood of angiographic coronary heart disease in hospitalized COPD patients, suggesting a potential protective or paradoxical metabolic relationship.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) conducted an observational in Chronic obstructive pulmonary disease (COPD) (n=407). Triglyceride-total cholesterol-body mass index (TCBI) vs. Low TCBI (lowest quartile) was evaluated on Likelihood of coronary heart disease (CHD) in COPD patients (OR 0.927 per 100-unit increase in TCBI, 95% CI 0.879-0.976, p=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: